Hapvida Participacoes e Investimentos (HAPV3) investor relations material

Executive summary

• Management is executing a strategic transformation plan focused on margin recovery, cash generation, deleveraging, and improving the user journey, with compensation tied to these metrics.

• Initiatives include commercial transformation, network optimization, administrative efficiency, legal restructuring, and investments in digital channels and process redesign.

• Net revenue grew 3.9% year-over-year and 1.0% sequentially, driven by higher average ticket size and price adjustments.

• Significant expansion activities included the acquisition of Grupo Cubo Mágico and the incorporation of São Lucas Saúde and related entities.

• Early signs of improvement in strategic portfolios and contract renegotiations, with a focus on profitability and stricter renewal criteria.

Financial highlights

• Net revenue reached R$7,974 million in 2Q26, up 3.9% year-over-year and 1.0% sequentially; 1H26 net revenue was R$15.87 billion.

• Adjusted EBITDA for 2Q26 was R$504.4 million (6.3% margin), down 44.3% year-over-year and 37.2% sequentially.

• Adjusted net income for 2Q26 was R$12.5 million, a sharp decline from R$299.5 million in 2Q25.

• Net debt increased to R$5,401 million as of June 2026, with leverage at 1.61x EBITDA LTM.

• Cash medical loss ratio (MLR) rose to 75.2% in 2Q26, up 303bps sequentially.

Outlook and guidance

• Management expects transformation initiatives and restructuring to yield results over the next quarters, with full impact anticipated by 2027.

• Focus on repricing or terminating loss-making contracts, optimizing network, and digitalizing administrative processes to drive margin recovery and cash generation.

• CapEx guidance for 2026 is about R$700 million, after R$363 million spent in the first half.

• ANS fines are expected to stabilize for two more quarters before decreasing.

• Management affirms sufficient resources and no material uncertainties regarding going concern for the next 12 months.